S
Satellos Bioscience Inc
TSX:MSCL
Satellos Bioscience Inc
TSX:MSCL
Price:
7.9
CAD
-0.88%
Market Cap:
CA$163m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Satellos Bioscience Inc
TSX:MSCL
|
CA |
|
GPGI Inc
NYSE:GPGI
|
US |
|
S
|
Sanofi SA
LSE:0O59
|
FR |
|
N
|
Ningbo Heli Technology Co Ltd
SSE:603917
|
CN |
|
Anheuser-Busch Inbev SA
MIL:ABI
|
BE |
|
Japan Real Estate Investment Corp
OTC:JREIF
|
JP |
|
B
|
BlueScope Steel Ltd
F:BH5
|
AU |
|
Invitation Homes Inc
NYSE:INVH
|
US |
|
iEntertainment Network Inc
OTC:IENT
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Coinbase Global Inc
NASDAQ:COIN
|
US |
|
L
|
LongFin Corp
OTC:LFIN
|
US |
Cash Flow Statement
Cash Flow Statement
Satellos Bioscience Inc
Satellos Bioscience Inc
Currency: CAD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(2)
|
(2)
|
(13)
|
(16)
|
(17)
|
(18)
|
(9)
|
(11)
|
(11)
|
(13)
|
(14)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
10
|
11
|
11
|
12
|
2
|
4
|
4
|
5
|
4
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
(0)
|
(1)
|
(2)
|
(1)
|
0
|
1
|
2
|
(1)
|
0
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+9%
|
(4)
-258%
|
(5)
-30%
|
(7)
-36%
|
(7)
-5%
|
(6)
+20%
|
(6)
+1%
|
(5)
+16%
|
(8)
-63%
|
(10)
-31%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
2
|
2
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
2
N/A
|
2
0%
|
2
0%
|
2
N/A
|
(0)
N/A
|
(0)
+71%
|
(0)
+36%
|
(0)
-309%
|
(0)
-87%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
1
|
1
|
0
|
0
|
3
|
3
|
0
|
58
|
51
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
(0)
|
|
| Other |
0
|
0
|
7
|
7
|
0
|
0
|
(0)
|
0
|
0
|
(4)
|
1
|
|
| Cash from Financing Activities |
0
N/A
|
0
+175%
|
8
+1 682%
|
7
-2%
|
7
-2%
|
7
-4%
|
3
-62%
|
3
+5%
|
5
+81%
|
56
+1 012%
|
51
-9%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
|
| Net Change in Cash |
(1)
N/A
|
(1)
+37%
|
5
N/A
|
4
-24%
|
2
-47%
|
2
-28%
|
(3)
N/A
|
(3)
+6%
|
0
N/A
|
47
+22 301%
|
41
-12%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
+9%
|
(4)
-258%
|
(5)
-30%
|
(7)
-36%
|
(7)
-5%
|
(6)
+19%
|
(6)
+1%
|
(5)
+16%
|
(8)
-63%
|
(10)
-31%
|
|
Switch to:
Switch to:
See Also
Discover More
